I
1.23
0.10 (8.85%)
Market Trend
Short Term | Medium Term | ||
Industry | Diagnostics & Research (US) | Mixed | Mixed |
Diagnostics & Research (Global) | Mixed | Mixed | |
Stock | Invitae Corporation | Mixed | Mixed |
AIStockmoo Score
-0.7
Analyst Consensus | NA |
Insider Activity | NA |
Price Volatility | -4.5 |
Technical Moving Averages | 2.5 |
Technical Oscillators | 0.0 |
Average | -0.67 |
Invitae Corp operates as a genetic information company in diagnostic and research industry. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions. |
|
Sector | Healthcare |
Industry | Diagnostics & Research |
Investment Style | Small Value |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |